Company intelligence / Profile preview

Forte Bio-Pharma

Las Vegas, Nevada, United Statesfortebiopharma.com ↗

Ownership: Private
Employees: ~26
Development stage: Other

Overview

Forte Bio‑Pharma is a privately held specialty pharmaceutical company focused on the in‑licensing, development, and commercialization of pain medications. Its main commercial products are opioid analgesic combinations such as NALOCET and Prolate tablets—both containing oxycodone plus acetaminophen—and Tanlor, which contains methocarbamol. The company emphasizes unique dosage options for healthcare providers, compliance with FDA regulations including REMS for opioids, and educational programs to mitigate risks associated with opioid use. There is no evidence of an R&D pipeline beyond these commercialized drugs.

Therapeutic areas: Neurology
Modalities: Small moleculeCombination drugs
Industry: Biotech

Partnerships

Collaborates with pharmacy partners to enhance product reach.

Beyond the preview

Go deeper on Forte Bio-Pharma.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Forte Bio-Pharma.

Explore the full profile